• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗生素开发方法与挑战简述:以药物再利用为重点

Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

机构信息

College of Pharmacy, The University of Texas at Austin, San Antonio, TX, United States.

Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, United States.

出版信息

Front Cell Infect Microbiol. 2021 May 17;11:684515. doi: 10.3389/fcimb.2021.684515. eCollection 2021.

DOI:10.3389/fcimb.2021.684515
PMID:34079770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8165386/
Abstract

Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as "antibiotic adjuvants" to enhance the activity of certain antibiotics.

摘要

药物重定位,或为现有药物寻找新用途,已成为替代传统药物发现过程(涉及合成)的一种方法。目前批准或正在开发用于非抗生素适应症的药物可能具有抗生素特性,因此可能具有单独或与抗生素联合使用的重定位潜力。它们也可以作为“抗生素佐剂”,增强某些抗生素的活性。

相似文献

1
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.新型抗生素开发方法与挑战简述:以药物再利用为重点
Front Cell Infect Microbiol. 2021 May 17;11:684515. doi: 10.3389/fcimb.2021.684515. eCollection 2021.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.针对临床医生的干预措施对基层医疗中急性呼吸道感染抗生素处方行为的影响:系统评价概述
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD012252. doi: 10.1002/14651858.CD012252.pub2.
5
FDA-approved drugs for targeting virulence of Pseudomonas aeruginosa: A drug repurposing approach to combat multidrug resistance.美国食品药品监督管理局(FDA)批准的针对铜绿假单胞菌毒力的药物:一种对抗多重耐药性的药物重新利用方法。
Microb Pathog. 2025 Sep;206:107781. doi: 10.1016/j.micpath.2025.107781. Epub 2025 Jun 3.
6
Idiopathic (Genetic) Generalized Epilepsy特发性(遗传性)全身性癫痫
7
Intracavity lavage and wound irrigation for prevention of surgical site infection.腔内灌洗和伤口冲洗预防手术部位感染
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD012234. doi: 10.1002/14651858.CD012234.pub2.
8
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.生物标志物作为即时检测手段,指导初级保健中急性呼吸道感染患者使用抗生素的处方。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.

引用本文的文献

1
Beyond One-Size-Fits-All: Addressing Methodological Constraints in Novel Antimicrobials Discovery.超越一刀切:解决新型抗菌药物发现中的方法学限制
Antibiotics (Basel). 2025 Aug 21;14(8):848. doi: 10.3390/antibiotics14080848.
2
Employing diclofenac sodium as a novel therapeutic frontier for Staphylococcus epidermidis infections.将双氯芬酸钠用作治疗表皮葡萄球菌感染的新前沿疗法。
Sci Rep. 2025 Aug 26;15(1):31377. doi: 10.1038/s41598-025-14316-1.
3
Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review.蛋白质组学对细菌抗生素反应的见解:一篇综述
Int J Mol Sci. 2025 Jul 27;26(15):7255. doi: 10.3390/ijms26157255.
4
Small-molecule strategies to combat antibiotic resistance: mechanisms, modifications, and contemporary approaches.对抗抗生素耐药性的小分子策略:作用机制、修饰及当代方法
RSC Adv. 2025 Jul 14;15(30):24450-24474. doi: 10.1039/d5ra04047g. eCollection 2025 Jul 10.
5
Antimicrobial Efficacy of Nd:YAG Laser in Polymicrobial Root Canal Infections: A Systematic Review of In Vitro Studies.钕钇铝石榴石激光对多菌性根管感染的抗菌效果:体外研究的系统评价
Int J Mol Sci. 2025 Jun 12;26(12):5631. doi: 10.3390/ijms26125631.
6
Strategic re-engineering of antibiotics.抗生素的战略重组
Nat Rev Bioeng. 2025 Mar;3(3):213-229. doi: 10.1038/s44222-024-00250-w. Epub 2024 Oct 15.
7
Organoselenium compounds as an enriched source for the discovery of new antimicrobial agents.有机硒化合物作为发现新型抗菌剂的丰富来源。
RSC Med Chem. 2025 Apr 7. doi: 10.1039/d4md00677a.
8
Synthesis and Biological Evaluation of Bicyclic Pyrazolines with Promising Antimicrobial Activities.具有潜在抗菌活性的双环吡唑啉的合成与生物学评价
ChemMedChem. 2025 Jul 18;20(14):e202500144. doi: 10.1002/cmdc.202500144. Epub 2025 May 27.
9
Insight into antistaphylococcal effect of chlorinated 1-hydroxynaphthalene-2-carboxanilides.对氯化1-羟基萘-2-甲酰苯胺抗葡萄球菌作用的洞察。
ADMET DMPK. 2025 Mar 26;13(2):2684. doi: 10.5599/admet.2684. eCollection 2025.
10
A Comprehensive Overview of Antibacterial Agents for Combating Multidrug-Resistant Bacteria: The Current Landscape, Development, Future Opportunities, and Challenges.对抗多重耐药菌的抗菌药物综合概述:现状、发展、未来机遇与挑战
Antibiotics (Basel). 2025 Feb 21;14(3):221. doi: 10.3390/antibiotics14030221.

本文引用的文献

1
It's Time to Reverse our Thinking: The Reverse Translation Research Paradigm.是时候扭转我们的思维了:反向翻译研究范式。
Clin Transl Sci. 2018 Mar;11(2):98-99. doi: 10.1111/cts.12538. Epub 2018 Feb 9.
2
Old Compounds, New Uses, New Ways: Many Ways.旧化合物、新用途、新方法:多种方式。
Assay Drug Dev Technol. 2017 Dec;15(8):353. doi: 10.1089/adt.2017.29067.hmu.
3
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016.2012 - 2016年美国食品药品监督管理局新型疗法的加速审批程序及临床开发时间
JAMA. 2017 Dec 5;318(21):2137-2138. doi: 10.1001/jama.2017.14896.
4
Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources.推进儿科风湿病药物治疗中的逆向翻译:资源有限的罕见病的合理方法。
Clin Transl Sci. 2018 Mar;11(2):106-108. doi: 10.1111/cts.12513. Epub 2017 Nov 28.
5
Repurposing Statins for Renal Protection: Is It a Class Effect?将他汀类药物用于肾脏保护:这是一种类效应吗?
Clin Transl Sci. 2018 Mar;11(2):100-102. doi: 10.1111/cts.12521. Epub 2017 Nov 15.
6
Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.激励抗生素药物研发创新:进展、挑战与下一步措施
J Antibiot (Tokyo). 2017 Dec;70(12):1087-1096. doi: 10.1038/ja.2017.124. Epub 2017 Nov 1.
7
Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant Infections.利用新的和现有的途径批准新的治疗方法来治疗严重的耐药感染。
Am J Law Med. 2016 May;42(2-3):429-450. doi: 10.1177/0098858816658275.
8
Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.金黄色葡萄球菌中NorA多药外排泵的优化外排测定法。
J Microbiol Methods. 2017 Nov;142:39-40. doi: 10.1016/j.mimet.2017.09.001. Epub 2017 Sep 5.
9
Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study.美国通过加速监管途径批准新药后与安全性相关的标签变更:回顾性队列研究
BMJ. 2017 Sep 7;358:j3837. doi: 10.1136/bmj.j3837.
10
Non-antibiotic treatment for infectious diseases.传染病的非抗生素治疗。
Rev Esp Quimioter. 2017 Sep;30 Suppl 1:66-71.